These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16052033)

  • 1. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus.
    Auriol E; Billard LM; Magdinier F; Dante R
    Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters.
    Wischnewski F; Friese O; Pantel K; Schwarzenbach H
    Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional methylation of the 5' end CpG island of BRCA1 is associated with reduced gene expression in human somatic cells.
    Magdinier F; Billard LM; Wittmann G; Frappart L; Benchaïb M; Lenoir GM; Guérin JF; Dante R
    FASEB J; 2000 Aug; 14(11):1585-94. PubMed ID: 10928993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2.
    Pulukuri SM; Rao JS
    Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
    Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
    Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific association between the methyl-CpG-binding domain protein 2 and the hypermethylated region of the human telomerase reverse transcriptase promoter in cancer cells.
    Chatagnon A; Bougel S; Perriaud L; Lachuer J; Benhattar J; Dante R
    Carcinogenesis; 2009 Jan; 30(1):28-34. PubMed ID: 18952593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells.
    Lin X; Nelson WG
    Cancer Res; 2003 Jan; 63(2):498-504. PubMed ID: 12543808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S; Tachibana K; Sekiya T; Hirohashi S; Shiraishi M
    Nucleic Acids Res; 2002 Nov; 30(21):4770-80. PubMed ID: 12409468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methyl-CpG-DNA binding proteins in human prostate cancer: expression of CXXC sequence containing MBD1 and repression of MBD2 and MeCP2.
    Patra SK; Patra A; Zhao H; Carroll P; Dahiya R
    Biochem Biophys Res Commun; 2003 Mar; 302(4):759-66. PubMed ID: 12646234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The essential role of histone H3 Lys9 di-methylation and MeCP2 binding in MGMT silencing with poor DNA methylation of the promoter CpG island.
    Zhao W; Soejima H; Higashimoto K; Nakagawachi T; Urano T; Kudo S; Matsukura S; Matsuo S; Joh K; Mukai T
    J Biochem; 2005 Mar; 137(3):431-40. PubMed ID: 15809347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A; Kantharidis P; Zalcberg JR; Wolffe AP
    Mol Cell Biol; 2002 Mar; 22(6):1844-57. PubMed ID: 11865062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA.
    Clouaire T; de Las Heras JI; Merusi C; Stancheva I
    Nucleic Acids Res; 2010 Aug; 38(14):4620-34. PubMed ID: 20378711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT; Gonzales FA; Jones PA
    Nucleic Acids Res; 2001 Nov; 29(22):4598-606. PubMed ID: 11713309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methyl-CpG-binding protein 2 represses LINE-1 expression and retrotransposition but not Alu transcription.
    Yu F; Zingler N; Schumann G; Strätling WH
    Nucleic Acids Res; 2001 Nov; 29(21):4493-501. PubMed ID: 11691937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of MBD1 and MeCP2 in prostate-cancer-derived PC3 cells produces differential gene expression profiles and cellular phenotypes.
    Yaqinuddin A; Abbas F; Naqvi SZ; Bashir MU; Qazi R; Qureshi SA
    Biosci Rep; 2008 Dec; 28(6):319-26. PubMed ID: 18666890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of human ribosomal RNA (rRNA) promoter methylation and of methyl-CpG-binding protein MBD2 in the suppression of rRNA gene expression.
    Ghoshal K; Majumder S; Datta J; Motiwala T; Bai S; Sharma SM; Frankel W; Jacob ST
    J Biol Chem; 2004 Feb; 279(8):6783-93. PubMed ID: 14610093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.